Evidence map›Paper›PMID 31527805›Full record

ArticleScientific reports2019

Effect of Cucumis sativus on Dysfunctional 3T3-L1 Adipocytes.

Méndez-Martínez Marisol, Trejo-Moreno Celeste, Maldonado-Mejía Laura, Esquivel-Guadarrama Fernando, Pedraza-Chaverri José, Zamilpa Alejandro, Medina-Campos Omar, Alarcón-Aguilar Francisco, Almanza-Pérez Julio César, Contreras-Nuñez Erika and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. GenusChinese herbal medicines · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Méndez-Martínez MarisolInstituto de Investigación en Ciencias Básicas y Aplicadas, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, CP, 62209, Mexico.
Trejo-Moreno CelesteInstituto de Investigación en Ciencias Básicas y Aplicadas, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, CP, 62209, Mexico.
Maldonado-Mejía LauraFacultad de Medicina, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, CP, 62350, Mexico.
Esquivel-Guadarrama FernandoFacultad de Medicina, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, CP, 62350, Mexico.
Pedraza-Chaverri JoséDepartamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México, Coyoacán, Ciudad de México, CP, 04510, Mexico.
Zamilpa AlejandroLaboratorio de Farmacología, Centro de Investigación Biomédica del Sur, Instituto Mexicano del Seguro Social, Xochitepec, Morelo, CP, 62790s, Mexico.
Medina-Campos OmarDepartamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México, Coyoacán, Ciudad de México, CP, 04510, Mexico.
Alarcón-Aguilar FranciscoDepartamento de Ciencias de la Salud, Universidad Autónoma Metropolitana de Iztapalapa, CDMX, C.P, 09640, Mexico.
Almanza-Pérez Julio CésarDepartamento de Ciencias de la Salud, Universidad Autónoma Metropolitana de Iztapalapa, CDMX, C.P, 09640, Mexico.
Contreras-Nuñez ErikaDepartamento de Ciencias de la Salud, Universidad Autónoma Metropolitana de Iztapalapa, CDMX, C.P, 09640, Mexico.
Santana-Calderón AngélicaCentro de Investigación en Dinámica Celular (IICBA), Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, CP, 62209, Mexico.
Fragoso GladisDepartamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México, CP, 04510, Mexico.
Jiménez-Ferrer EnriqueLaboratorio de Farmacología, Centro de Investigación Biomédica del Sur, Instituto Mexicano del Seguro Social, Xochitepec, Morelo, CP, 62790s, Mexico. enriqueferrer_mx@yahoo.com.
Rosas GabrielaInstituto de Investigación en Ciencias Básicas y Aplicadas, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, CP, 62209, Mexico. gabriela.rosas@uaem.mx.
Universidad Autónoma del Estado de Morelos · MXUniversidad Autónoma Metropolitana · MXUniversidad Nacional Autónoma de México · MXMexican Social Security Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity is caused by lipid accumulation in adipose tissues inducing adipocyte dysfunction, characterized by insulin resistance, increased lipolysis, oxidative stress, and inflammation, leading to increased levels of adipokines. Herein the capacity of the subfractions (SFs) SF1, SF2, and SF3 from the Cucumis sativus aqueous fraction and their combinations (M) to control adipocyte dysfunction in vitro, in 3T3-L1 adipocytes was studied. Adipocytes, previously treated with dexamethasone or IL-1 to induce dysfunction, were incubated with different concentrations of the subfractions for 24 h. 2-deoxyglucose consumption and glycerol release were evaluated, and a surface model was constructed to determine the most effective SF concentrations to improve both parameters. Effective SF combinations were assessed in their capacity to control metabolic, pro-oxidative, and pro-inflammatory conditions. SF1, SF2 (40 μg/ml each) and SF3 (20 μg/ml) improved 2-deoxyglucose consumption by 87%, 57%, and 87%, respectively. SF1 and SF2 (5 μg/ml each) and SF3 (40 μg/mL) increased glycerol secretion by 10.6%, 18.9%, and 11.8%, respectively. Among five combinations tested, only M4 (SF1 40 μg/ml:SF2 60 μg/ml:SF3 30 μg/ml) and M5 (SF1 40 μg/ml:SF2 60 μg/mL:SF3 10 μg/ml) controlled effectively the metabolic, pro-oxidative, and proinflammatory conditions studied. Glycine, asparagine, and arginine were the main components in these SFs.

Indexed as

3T3-L1 CellsAdipocytesAdipokinesAdipose TissueAnimalsCell DifferentiationCucumis sativusInflammationInsulinInsulin ResistanceMiceObesityOxidative StressPlant ExtractsAdipokinesInsulinPlant Extracts

Identifiers

PMID31527805
PMCPMC6746747
OpenAlexW2974211856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.